:

LEGRAND RAISES OUTLOOK ON AI DATA CENTER BOOM

INDUSTRY DESK1 MIN READ
WED, JUL 29, 2026

■ AI-SUMMARIZED FROM 5 SOURCES ▸ TIMELINE

Legrand SA increased its sales guidance as customers accelerate spending on artificial intelligence infrastructure. The French electrical equipment manufacturer benefits from surging demand for data center construction and expansion.

Legrand, a global provider of electrical and digital building infrastructure, upgraded its financial outlook citing robust client investment in AI-related data center projects. The company supplies power distribution, cooling systems, and connectivity solutions essential for large-scale data center operations. Data center operators and hyperscalers are ramping up capital expenditure to support growing AI workloads and model training. This spending wave extends across major cloud providers and technology companies building out computational capacity. The guidance lift reflects Legrand's position as a critical supplier in the data center supply chain. As infrastructure spending continues, companies providing physical building systems and electrical components stand to capture significant revenue growth. Legrand's elevated outlook aligns with industry trends showing data center investment remaining a primary driver of technology infrastructure spending through 2024 and beyond.

■ SOURCES

Bloomberg TechWiredBloomberg TechBloomberg TechBloomberg Tech

■ SUMMARY WRITTEN BY AI FROM THE LINKS ABOVE

■ MORE FROM THE BUSINESS DESK

The Senate has advanced the latest version of the Kids Online Safety Act out of committee. The House passed its own version of the contentious bill in June.

JUST NOWIndustry Desk

Matt McLennan, head of First Eagle Investments' Global Value Team, warns that excessive market focus on artificial intelligence has created dangerous complacency among investors.

1H AGOAI Desk

Flipkart's payments app Super.money is expanding into e-commerce, enabling users to purchase items through interest-free installment plans. The move broadens the company's fintech offerings beyond payments.

1H AGOIndustry Desk

The FDA has approved Moderna's mFLUSIVA, an mRNA-based flu vaccine for adults 50 and older. The approval marks the first seasonal flu vaccine using messenger RNA technology.

2H AGOIndustry Desk

■ SUBSCRIBE TO THE DAILY BRIEF

ONE EMAIL, 5 STORIES, 06:00 UTC. UNSUBSCRIBE ANYTIME.